Unlock instant, AI-driven research and patent intelligence for your innovation.

Use of indole compounds in the preparation of medicines

A compound, indole technology, applied in the field of medicine

Active Publication Date: 2021-07-27
HAINAN HONZ PHARMA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the large number of members of the TRPC protein family and the high similarity of amino acid sequences, different members can be aggregated to form heterotetramers, resulting in a large variety of protein channels in this family, and no specific inhibitors for TRPC6 have been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of indole compounds in the preparation of medicines
  • Use of indole compounds in the preparation of medicines
  • Use of indole compounds in the preparation of medicines

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0075] Example 1: Preparation of 3-[(1-methyl-1H-indole-2-carbonyl)amino]propionic acid (compound 1-1)

[0076]

[0077] Step 1: Preparation of ethyl 3-[(1-methyl-1H-indole-2-carbonyl)amino]propionate (intermediate B-1)

[0078] Compound A-1,1-methylindole-2-carboxylic acid (3.61 g, 20.62 mmol) was dissolved in 15 mL of anhydrous CH 2 Cl 2 In, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI, 4.35 g, 22.69 mmol) was dissolved in 10 mL of anhydrous CH 2 Cl 2 In, β-alanine ethyl ester hydrochloride (3.49 g, 22.72 mmol) and 4-dimethylaminopyridine (DMAP, 4.26 g, 34.86 mmol) were dissolved in 20 mL of anhydrous CH 2 Cl 2 , then the above three solutions were mixed, stirred in an ice bath for 4 h, and then placed at room temperature to react, and TLC monitored that the reaction was complete. 10mL CH 2 Cl 2 Extract three times, collect the lower layer solution through anhydrous Na 2 SO 4 It was dried overnight, filtered, concentrated under reduced pressu...

Embodiment 2

[0083] Example 2: Preparation of N-(1H-indole-2-carbonyl)-glycine methyl ester (compound 2-1)

[0084]

[0085] Step 1: Preparation of N-(3-(2-nitrophenyl)-pyruvyl)-glycine methyl ester (intermediate E-1)

[0086] Compound D-1 (0.44 g, 1.20 mmol) was dissolved in 10 mL of methanol solution containing 10% (volume ratio) concentrated hydrochloric acid, stirred and refluxed for 2.5 h, and the reaction was monitored by TLC. After cooling to room temperature, the solution was filtered and the solvent was evaporated. A quantitative amount of ethyl acetate was added to the residue and washed with brine, washed over anhydrous Na 2 SO 4 It was dried, filtered and concentrated, and purified by silica gel column chromatography [eluent: V (hexane): V (ethyl acetate) = 3: 2] to obtain intermediate E-1 as a yellow solid (0.26 g).

[0087] Step 2: Preparation of N-(1H-indole-2-carbonyl)-glycine methyl ester (compound 2-1)

[0088] Compound E-1 (0.26 g, 10 mmol) was dissolved in 10 mL ...

Embodiment 3

[0090] Example 3: Preparation of N-(1H-6-aminoindole-2-carbonyl) glycine methyl ester (compound 2-2)

[0091]

[0092] Step 1: Preparation of N-(3-(2,4-dinitrophenyl)pyruvyl)glycine methyl ester (intermediate E-2)

[0093] Compound D-2 (1.341 g, 3.0 mmol) was dissolved in 1 mL of methanol solution containing 10% (volume ratio) concentrated hydrochloric acid, sealed, stirred at 130° C. for 5 minutes, and monitored by TLC. After cooling to room temperature, the solution was filtered and the solvent was evaporated in vacuo. Add 50 mL of ethyl acetate to the residue, wash with 50 mL of brine, wash over anhydrous Na 2 SO 4 It was dried, filtered and concentrated, and purified by silica gel column chromatography [eluent: V (hexane): V (ethyl acetate) = 3: 2] to obtain compound E-2 (1.0179 g) as a yellow solid.

[0094] Step 2: Preparation of N-(1H-6-aminoindole-2-carbonyl)glycine methyl ester (compound 2-2)

[0095] Compound E-2 (0.906 g, 10 mmol) was dissolved in 20 mL of ethy...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine and relates to the application of indole compounds in the preparation of medicines. Specifically, it relates to indole compounds represented by the following general formula (I) or their isomers or their pharmaceutically acceptable salts or their esters or their solvates or their prodrugs in the preparation of TRPC6 inhibitor drugs Therefore, it can be used to prevent or treat kidney disease, hypertension, heart failure, cardiac hypertrophy, arrhythmia, myocarditis, arthritis, bronchitis, neuritis, sepsis, pulmonary hypertension, atherosclerosis or tumor.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to the application of indole compounds in the preparation of medicines. Background technique [0002] Canonical transient receptor potential channels (TRPC Channels) are a class of Ca 2+ Permeable, nonselective cation channel with diverse transmembrane signal transduction functions. Up to now, a total of 7 subtypes of TRPC1-7 have been discovered. According to the similarity of protein amino acid sequence and protein function, they can be divided into 4 categories: TRPC1, TRPC2, TRPC3 / 6 / 7, TRPC4 / 5[Wang Y , Bu J, Shen H, et al. Targeting transient receptor potential canonical channels for diseases of the nervous system. Curr. Drug Targets, 2017, 18(12): 1460-1465], in which TRPC2 is not expressed in mammals, so it is called pseudogenes. The activation of TRPC channels can be regulated by a variety of factors including temperature, pH, osmotic pressure, mechanical force and some endo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D209/42C07D209/58A61P9/12A61P9/06A61P13/12A61P3/00A61P3/10A61P3/04A61P31/20A61P31/00A61P19/02A61P29/00A61P9/10A61P35/00A61P31/04A61P9/04A61K31/404A61K31/403
CPCA61P3/00A61P3/04A61P3/10A61P9/04A61P9/06A61P9/10A61P9/12A61P13/12A61P19/02A61P29/00A61P31/00A61P31/04A61P31/20A61P35/00C07D209/42C07D209/58
Inventor 曹蔚
Owner HAINAN HONZ PHARMA